In Singapore, updates to a registered drug are managed by the Health Sciences Authority (HSA). Companies must submit variation applications detailing changes, which are categorized as minor or major. The HSA reviews these applications to ensure continued safety, efficacy, and quality before approving the updates for implementation.
